Revvity | Kamatkiadások



Interest Expense On Debt változás Dátum
Agilent USD 28M 4M 2025-01
Align Technology 0 0 2024-09
Bio Techne USD 2.15M 28K 2024-12
Bio-Rad Laboratories USD 12.2M 26K 2024-12
Bruker USD 8M 4.8M 2024-12
Celltrion KRW 18.38B 907.05M 2024-09
Charles River Laboratories USD 28.23M 2.05M 2024-12
Cspc Pharmaceutical 11.32M 4.55M 2024-09
Danaher USD 61M 26M 2024-12
Dentsply International USD 16M 2M 2024-12
Dianthus Therapeutics 4.44M 4.44M 2024-09
Ecofibre AUD 761K 773K 2024-06
Edwards Lifesciences 15.5M 1000K 2024-06
Exact Sciences USD 9.58M 30K 2024-12
Hologic USD 30.5M 1.5M 2024-12
Illumina USD 25M 11M 2024-12
IQVIA Holdings USD 171M 1000K 2024-12
Kangmei Pharma CNY 3.12M 140.6K 2023-09
Knight Therapeutics CAD 1.91M 369K 2024-09
Laboratory Of America USD 63.4M 13M 2024-12
Medical Developments International AUD 21K 23K 2024-06
Mettler Toledo International USD 17.85M 749K 2024-12
Myriad Genetics USD 700K 100K 2024-12
Neuren Pharmaceuticals 0 0 2024-06
Patterson Companies USD 10.75M 1.04M 2025-01
Qiagen NV USD 11.14M 337K 2024-12
Quest Diagnostics USD 65M 16M 2024-12
Quidel USD 44.7M 1.4M 2024-12
Repligen USD 5.46M 88K 2024-12
Revvity USD 22.78M 1.6M 2024-12
Sartorius 48.9M 41.76M 2024-09
Sino Biopharmaceutical CNY 76.87M 114.23M 2024-06
Thermo Fisher Scientific USD 316M 40M 2024-12
Tilray USD 7.77M 2.08M 2024-11
Waters USD 19M 1.82M 2024-12
Zz Pientze Pharmaceu 9.17M 60K 2024-09



Revvity Kamatkiadások - Az oldal aktuális és múlbeli adatokat, elorejelzéseket, statisztikákat, grafikonokat és a gazdasági naptár adatait tartalmazza - Mar 2025.